Pollen Shape Particles for Pulmonary Drug Delivery: In Vitro Study of Flow and Deposition Properties

IFMBE Proceedings

Volumn 23, Issue , 2009, Pages 1434-1437

  Hassan, Meer Saiful ^a   Lau, Raymond ^a  

^a NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

cascade impactor; emitted dose; fine particle fraction; pollen shape particles; Pulmonary drug delivery

Indexed keywords

CASCADE IMPACTORS; EMITTED DOSE; FINE PARTICLE FRACTIONS; PULMONARY DRUG DELIVERY; SHAPE PARTICLES;

BIOMEDICAL ENGINEERING; DEPOSITION; METEOROLOGICAL INSTRUMENTS;

AGGLOMERATION;

EID: 84891922595     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-540-92841-6_354     Document Type: Conference Paper

References (11)

1. Hicky A J (2004) Pharmaceutical Inhalation Aerosol Technology, Marcel Dekker, Inc., New York.
2. Edwards D A (2002) Delivery of biological agents by aerosols. AIChE Journal 48(1):2-6.
3. Crowder T M, Rosati J A, Schroeter J D et al. (2002) Fundamental Effects of Particle Morphology on Lung Delivery: Predictions of Stokes' Law and the Particular Relevance to Dry Powder Inhaler Formulation and Development. Pharm Res 19(3):239-245
4. Visser J (1989) Van der Waals and other cohesive forces affecting powder fluidization. Powder Technol 58(1):1-10
5. Wang Y, Gunawan P, Xu R (2008) Polyelectrolyte-mediated formation o hydroxyapatite microspheres: From anisotropic to isotropic growth. Submitted
6. Yu J, Tang H, Cheng B et al. (2004) Morphological control of calcium oxalate particles in the presence of poly-(styrene-alt-maleic acid). J Solid State Chem 177(10):3368-3374
7. Yu J, Lei M, Cheng B et al. (2004) Facile preparation of calcium carbonate particles with unusual morphologies by precipitation reaction. J Cryst Growth 261(4):566-570
8. Lucas A, Gaude J, Carel C et al. (2001) A synthetic aragonite-based ceramic as a bone graft substitute and substrate for antibiotics. Int J Inorg Mater 3:87-94
9. Shi L, C J Plumley, C Berkland (2007) Biodegradable Nanoparticle Flocculates for Dry Powder Aerosol Formulation. Langmuir 23(22):10897-10901
10. Larhrib H, Martin G P, Marriott C et al. (2003) The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int J Pharmaceutics 257(1-2):283-296
11. French D L, Edwards D A, Niven R W (1996) The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation. J Aerosol Sci 27:769-783